Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine reported to EudraVigilance database

Mansour Tobaiqy, Hajer Elkout, Katie MacLure
doi: https://doi.org/10.1101/2021.03.19.21253980

Article Information

doi 
https://doi.org/10.1101/2021.03.19.21253980
History 
  • March 21, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Mansour Tobaiqy1,*,
  2. Hajer Elkout2 and
  3. Katie MacLure3
  1. 1Associate Professor, Department of Pharmacology, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia. mtobaiqy{at}uj.edu.sa
  2. 2Department of Family and Community Medicine, Medical faculty, University of Tripoli, Tripoli, Libya. H.elkout{at}yahoo.com
  3. 3Independent Research Consultant, Aberdeen, UK. katiemaclure{at}outlook.com
  1. ↵*Corresponding Author: Dr. Mansour Tobaiqy, mtobaiqy{at}uj.edu.sa
Back to top
Posted March 21, 2021.
Download PDF
Data/Code
Email
Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine reported to EudraVigilance database
Mansour Tobaiqy, Hajer Elkout, Katie MacLure
medRxiv 2021.03.19.21253980; doi: https://doi.org/10.1101/2021.03.19.21253980
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area